Literature DB >> 8812691

Function and Regulation of Natural Killer (NK) Cells during Viral Infections: Characterization of Responses in Vivo

.   

Abstract

Although in vitro systems have provided important information about the composition and nature of various immune responses, understanding physiologically relevant function and regulation requires evaluating in vivo conditions. Two different models of acute viral infections have made possible the characterization of a variety of responses to these agents, including natural killer (NK) cell activation and regulation during infection; these are mouse infections with lymphocytic choriomeningitis virus (LCMV) and murine cytomegalovirus (MCMV). The results of our characterization of the NK cell responses elicited in these models and the methods used to dissect the regulation of these responses are reviewed here. Cytotoxicity, proliferation, and cytokine expression assays as well as flow cytometric analyses are used to characterize the in vivo responses. Both of the infections induce early NK cell cytotoxicity and blastogenesis. Infection with MCMV but not LCMV also induces NK cell production of the antiviral cytokine, interferon-gamma (IFN-gamma). Antibodies, to mediate in vivo cell subset depletion or cytokine neutralization, and mice, genetically altered to have cell subset or cytokine deficiencies, are utilized to identify the regulatory pathways and mechanisms controlling endogenous NK cell responses to the infections. The major mediators of the regulation of NK cell function during viral infection of normal mice are IFN-alpha/beta and interleukin-12 but not interleukin-2. Furthermore, the induction of later T-cell responses contributes to the negative regulation of NK cells by promoting the production of inhibitory factors including biologically active transforming growth factors-beta. Thus, the study of immune responses to viral infections has provided and will continue to provide important insights into the characteristics of endogenous NK cell responses and the cells and factors that regulate these responses in vivo.

Entities:  

Year:  1996        PMID: 8812691     DOI: 10.1006/meth.1996.0043

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  10 in total

Review 1.  Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.

Authors:  Seung-Hwan Lee; Christine A Biron
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

2.  Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.

Authors:  Julian J Lum; David J Schnepple; Zilin Nie; Jaime Sanchez-Dardon; Georgina L Mbisa; Jennifer Mihowich; Nanci Hawley; Shanil Narayan; John E Kim; David H Lynch; Andrew D Badley
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity.

Authors:  Malin Bengnér; Vivien Béziat; Jan Ernerudh; Bengt-Olof Nilsson; Sture Löfgren; Anders Wikby; Karl Johan Malmberg; Jan Strindhall
Journal:  Age (Dordr)       Date:  2013-09-25

4.  Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex.

Authors:  Nassima Fodil-Cornu; Seung-Hwan Lee; Simon Belanger; Andrew P Makrigiannis; Christine A Biron; R Mark Buller; Silvia M Vidal
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Tumor growth impedes natural-killer-cell maturation in the bone marrow.

Authors:  John O Richards; Xing Chang; Bradley W Blaser; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

Review 6.  Natural killer cells and antifungal host response.

Authors:  Stanislaw Schmidt; Stefanie-Yvonne Zimmermann; Lars Tramsen; Ulrike Koehl; Thomas Lehrnbecher
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

Review 7.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 8.  Control of HCV Infection by Natural Killer Cells and Macrophages.

Authors:  Hugo R Rosen; Lucy Golden-Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

9.  NK cell-like behavior of Valpha14i NK T cells during MCMV infection.

Authors:  Johnna D Wesley; Marlowe S Tessmer; Deanna Chaukos; Laurent Brossay
Journal:  PLoS Pathog       Date:  2008-07-18       Impact factor: 6.823

10.  Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

Authors:  Mohammad S Hossain; Sampath Ramachandiran; Andrew T Gewirtz; Edmund K Waller
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.